Flexible, Responsive Capital
Life Science companies utilize debt financing solutions to accelerate or broaden the scope of their clinical development, invest in new R&D or commercial infrastructures, acquire external clinical assets, extend their cash runway past important value inflection points, or shore-up their balance sheets ahead of an IPO or negotiations with strategic partners. In this vertical, Hercules Capital focuses on the following sectors:
Drug Discovery, Drug Platform, Drug Delivery, Specialty Pharma, Life Sciences Tools, Medical Devices, and more.
LIFE SCIENCES TEAM
LIFE SCIENCES TEAM
R. Bryan Jadot Senior Managing Director and Group Head - Life Sciences
Kristen Kosofsky Senior Managing Director
Janice Bourque Managing Director
Lake McGuire Managing Director
Nimesh Shah Managing Director
Mike Dutra Principal
Himani Bhalla Principal
Michael Bowden MD Portfolio Management
Ana Maria Petrovic Vice President
Ana Petrovic joined Hercules in 2018 as a Vice President in the Life Sciences Group. Prior to that she served as the Director of Investor Relations and Corporate Development at Fluidigm, a life science tools company. Before joining Fluidigm, she worked at several investment banks in sell-side equity research covering biotech and specialty pharmaceuticals equities. Earlier in her career, Ana was a biologist at the National Institutes of Health.
Ms. Petrovic received her MBA from the University of Chicago, Booth School of Business; a MS in Biochemistry from George Washington University; and a BS in Microbiology from the University of Maryland.
Featured Portfolio Companies
Anacor Pharmaceuticals, Inc.
Hercules Capital is a strong long-term partner for TransMedics. The Hercules team took the time to work with the management team to understand the business opportunity and challenges that we faced. They have used that knowledge to strategically support the company throughout its key stages of development. They are more than a venture debt lender, they are a business partner that focuses on helping their portfolio companies succeed and grow. TransMedics and I are fortunate to be working with the Hercules team.
Waleed Hassanein, M.D. (President & CEO, TransMedics )